List view / Grid view
The Queen’s Award for Enterprise in Innovation was awarded to…
The Queen’s Award for Enterprise in Innovation was awarded to GW for leadership in cannabinoid science and development of prescription cannabis-based medicines.
The cannabidiol-based treatment EPIDYOLEX has been granted marketing authorisation from…
The cannabidiol-based treatment EPIDYOLEX has been granted marketing authorisation from the European Commission.
EMA’s human medicines committee had cleared the cannabidiol oral solution,…
EMA’s human medicines committee had cleared the cannabidiol oral solution, Epidiolex, for use to treat seizures.
